LEXINGTON, Mass.--(BUSINESS WIRE)--MC10, Inc. today announced that Eric K. Brandt has been appointed to the company's Board of Directors.
“I am pleased to announce the appointment of Eric K. Brandt to the MC10 Board of Directors. Eric brings a wealth of experience to the MC10 Board. He has extensive financial knowledge from both the semiconductor and healthcare industries, which offers a unique combination that will be an asset to the Board and to our overall business. We welcome Eric and look forward to the contributions he will make,” stated Scott D. Pomerantz, MC10’s Chief Executive Officer, President and executive member of the Board of Directors.
Mr. Brandt served as Executive Vice President and Chief Financial Officer of Broadcom Corporation (NASDAQ:BRCM), a position he held between March 2007 and January 2016. In February 2016, Eric helped lead the largest semiconductor acquisition in history when Avago Technologies Limited (NASDAQ: AVGO) acquired Broadcom Corporation for ~$37 billion. Mr. Brandt served as President and Chief Executive Officer of Avanir Pharmaceuticals (NASDAQ: AVNR) from September 2005 through March 2007. Prior to joining Avanir, Mr. Brandt was Executive Vice President of Finance and Technical Operations and Chief Financial Officer of Allergan, Inc. (NYSE: AGN), a global specialty pharmaceutical and medical device company. He also held a number of other senior positions at Allergan following his arrival there in 1999. Mr. Brandt previously spent ten years with The Boston Consulting Group, a privately-held global business consulting firm, most recently serving as Vice President, Partner, and senior member of its healthcare practice.
Mr. Brandt was appointed to the Yahoo (NASDAQ: YHOO) Board of Directors this March. He also serves as a member of the Board of Directors of Dentsply International, Inc. (NASDAQ: XRAY), a manufacturer and distributor of dental and other consumable healthcare products, and Lam Research Corporation (NASDAQ: LRCX), a leading manufacturer of semiconductor capital equipment. He has also previously served as a member of the Boards of Directors of Avanir and of Vertex Pharmaceuticals, Inc. (NASDAQ: VRTX).
Mr. Brandt earned his Bachelor of Science Degree in Chemical Engineering from the Massachusetts Institute of Technology and Master of Business Administration Degree from the Harvard Business School. He has been named one of the best CFOs in America 5 times by Institutional Investor magazine.
About MC10, Inc.
MC10 is a private
company, backed by a strong syndicate of financial and strategic
investors, that is improving human health through digital healthcare
solutions. The company combines its proprietary ultra-thin, flexible
body-worn sensors with advanced analytics to unlock health insights from
physiological data. MC10 has received widespread recognition for its
revolutionary technology and was recently named in Fast Company’s Most
Innovative Companies in 2016 as a leader in healthcare. MC10 is
headquartered in Lexington, MA. Visit MC10 online at www.mc10inc.com.
MC10® and the MC10 logo are registered marks owned by MC10, Inc.
